The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans. - Wikidata - awgldk - TriplyDB

The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

http://www.wikidata.org/entity/Q35142847

about

Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis Liver X receptors at the intersection of lipid metabolism and atherogenesis Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population Association of MYLIP rs3757354 SNP and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci.Genetics of familial hypercholesterolemia.The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis.A powerful statistical framework for generalization testing in GWAS, with application to the HCHS/SOL.miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules.The Use of L-sIDOL Transgenic Mice as a Murine Model to Study Hypercholesterolemia and Atherosclerosis.Running training experience attenuates disuse atrophy in fast-twitch skeletal muscles of rats.

P2860

Q27026250-5A7F3BB7-5CDF-4A5A-AACA-7ED6A442002C Q28082452-8F31DE2B-8B71-42F2-9F44-60F21C90A6EC Q33759643-DED4E727-F754-4CCB-A10A-B45F0BFE294C Q33992107-5303DE79-536C-4997-82EB-4FA4C9496595 Q34387744-16749E2A-602B-407C-B1BF-8253D7B5B087 Q34667908-2D3B6129-5367-4CAA-97F3-02D0EA01E3CA Q35557701-86BF4BE7-9DE1-4B27-B1BE-9B133837528B Q35647668-62063AC9-CCE9-44F4-BBDB-448B592C2500 Q36226649-C2FBE324-E45E-471D-962E-D456FCFF1326 Q36394580-A82E47F0-C6E2-4BD0-9CD7-4EE1958AD05E Q36410753-07D2A922-2AF0-45D9-BFB8-CD871ADDEC3A Q36702427-22F4D923-A901-4C52-8688-C9234F5B1F5C Q37567281-288B0282-F220-44EB-9D3C-C845089F264B Q38364881-93849EB3-AC0E-43C3-BFD3-5D21F58EF685 Q38818532-77F7468B-976E-4A6A-AE16-8C502C62F6BC Q40379695-621220DE-3308-40DD-858B-22696DBB4070 Q41984092-B40FB5CF-8171-407E-B765-3085911A1321 Q50862164-055F6D91-09D3-4048-927D-FB6364F585CA Q53126489-CE753772-B8BE-49E5-AAE8-B22D32423678

P2860

The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

http://www.wikidata.org/entity/Q35142847

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@ast

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@en

type

label

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@ast

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@en

prefLabel

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@ast

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@en

P1433

Q35142847-B61663FE-858F-453C-8993-D47EA6ED9234

P1476

Q35142847-D47DA3A8-2ADB-42A9-BA08-C8C4118C020F

P2093

Q35142847-22023174-198C-4D9C-BED5-9AB98E73B6D6

Q35142847-81B9CC48-DF95-49EB-A637-D3DC922BBCBD

Q35142847-8B627AC1-4D60-468F-8A39-FBD621BD02E5

Q35142847-9B491920-2EC4-4643-92D2-503352DE2B72

Q35142847-9E6E105B-F317-4742-82F6-855D4864AAA2

Q35142847-BE259E45-DE4C-4876-913F-9E95D91DD3F1

Q35142847-D2E4699C-0692-4782-A00F-F8A68F43976F

Q35142847-E0F5E779-0F08-45C7-92CB-C9198B978EA1

Q35142847-E17F3673-3137-4CB5-8532-6637FB1B1C08

Q35142847-E3A1AEDD-5642-4BF0-B6A3-F50C1F95975A

P2860

Q35142847-0047744D-42B6-4DE1-93DE-70714761CBE8

Q35142847-17999690-1B3D-43FA-8D0A-23671DB484F6

Q35142847-1A6FD119-1535-4120-B2AE-F05DDFBBF786

Q35142847-1F4EE315-1A99-4C8F-8CE4-A01A1639E488

Q35142847-2E3592AA-36E1-4E8D-866C-02FEACFDCA78

Q35142847-341702D9-0761-42FD-848B-C0D4B520A6B3

Q35142847-360F45E4-4776-4B3C-8295-5849B703B750

Q35142847-3C5CF789-1931-428F-B6F5-379658648A41

Q35142847-40DB9F57-E50E-473B-A773-C1AD97A705B6

Q35142847-41F8374B-6F56-40C4-95D0-5423F4D4B089

P304

Q35142847-5D494978-0B17-4A42-BD85-110D371B6047

P31

Q35142847-1338DDB3-CF02-4E0A-BB46-360B6BFCCA8D

P356

Q35142847-FC41524D-D473-4E56-9387-91C9A8684414

P407

Q35142847-DBE16487-9E9C-48E5-83C8-3868BDA1FE4A

P433

Q35142847-A2A33324-684B-49F6-B0CB-49CDEC1CC3B5

P478

Q35142847-AFC30EF4-8017-4A62-AC59-A86661052CC4

P50

Q35142847-1931096A-F2DA-4988-8FDD-45B051809B35

Q35142847-4AC49E23-FFD1-4C41-8FA6-95D65E49FAD1

P577

Q35142847-657BF5D3-A50D-4618-B073-277AB821A2DD

P5875

Q35142847-36871539-EC58-400F-B17C-78AB86D752F2

P698

Q35142847-EF075A3D-EEE9-48D7-A2BC-916DCB358D4D

P932

Q35142847-F36288C1-EE1B-450A-8443-59EE143CBBF9

P356

P1433

Journal of Clinical Investigation

P1476

The N342S MYLIP polymorphism i ...... eceptor degradation in humans.

@en

P2093

Ana Maria Vargas Tino

http://www.w3.org/2001/XMLSchema#string

Anna C Calkin

http://www.w3.org/2001/XMLSchema#string

Carlos A Aguilar-Salinas

http://www.w3.org/2001/XMLSchema#string

Daphna Weissglas-Volkov

http://www.w3.org/2001/XMLSchema#string

Ivette Cruz-Bautista

http://www.w3.org/2001/XMLSchema#string

Janet S Sinsheimer

http://www.w3.org/2001/XMLSchema#string

Laura Riba

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Ordoñez-Sánchez

http://www.w3.org/2001/XMLSchema#string

Noam Zelcer

http://www.w3.org/2001/XMLSchema#string

Päivi Pajukanta

http://www.w3.org/2001/XMLSchema#string

P2860

A flexible and accurate genotype imputation method for the next generation of genome-wide association studies

Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis

Functional activities and cellular localization of the ezrin, radixin, moesin (ERM) and RING zinc finger domains in MIR

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

Biological, clinical and population relevance of 95 loci for blood lipids

Signals of recent positive selection in a worldwide sample of human populations

LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor

PLINK: a tool set for whole-genome association and population-based linkage analyses

A haplotype map of the human genome

P304

3062-3071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45504

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Daphna Weissglas-Volkov

P577

2011-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51498469

http://www.w3.org/2001/XMLSchema#string

P698

21765216

http://www.w3.org/2001/XMLSchema#string

P932

3148733

http://www.w3.org/2001/XMLSchema#string